We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+9.29%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$2.5B
AUM Growth
-$325M
Cap. Flow
-$480M
Cap. Flow %
-19.19%
Top 10 Hldgs %
43.13%
Holding
114
New
31
Increased
17
Reduced
20
Closed
42

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$104M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$96.5M
3
BMY icon
Bristol-Myers Squibb
BMY
+$96.1M
4
TMO icon
Thermo Fisher Scientific
TMO
+$86.3M
5
NTRA icon
Natera
NTRA
+$80.8M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$115M
2
INCY icon
Incyte
INCY
+$95.4M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$79.2M
4
ABBV icon
AbbVie
ABBV
+$78.9M
5
IQV icon
IQVIA
IQV
+$77.6M

Sector Composition

Rank Sector Weight
1 Healthcare 88.3%
2 Consumer Discretionary 4.43%
3 Real Estate 2.56%
4 Financials 1.86%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHC icon
101
Sotera Health
SHC
$5.44B
– –
-805,220
Closed -$20.1M
SPY icon
102
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$818B
– –
-85,000
Closed -$33.7M
TIL icon
103
Instil Bio
TIL
$48.9M
– –
-10,000
Closed -$5.02M
TNGX icon
104
Tango Therapeutics
TNGX
$4.69B
– –
-41,032
Closed -$456K
TVTX icon
105
Travere Therapeutics
TVTX
$6.05B
– –
-618,520
Closed -$15.4M
PRDS
106
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
– –
-350,000
Closed -$3.49M
FNCH
107
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
– –
-5,000
Closed -$2.42M
LGV.U
108
DELISTED
Longview Acquisition Corp. II Units, each consisting of one share of Class A Common Stock and one-fifth of one redeemable Warrant
LGV.U
– –
-1,750,000
Closed -$17.6M
OHPAU
109
DELISTED
Orion Acquisition Corp. Unit
OHPAU
– –
-582,920
Closed -$5.83M
CERN
110
DELISTED
Cerner Corp
CERN
– –
-74,420
Closed -$5.35M
NUAN
111
DELISTED
Nuance Communications, Inc.
NUAN
– –
-742,030
Closed -$32.4M
CMIIU
112
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
– –
-173,563
Closed -$2.22M
KIN
113
DELISTED
Kindred Biosciences, Inc.
KIN
– –
-265,580
Closed -$1.32M
MSACU
114
DELISTED
Medicus Sciences Acquisition Corp. Unit
MSACU
– –
-790,000
Closed -$7.78M
1 2 3 4
5

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q2 2021 Portfolio in Review

As of Q2 2021, HealthCor Management held 114 positions worth $2.5B, down 11% from $2.83B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

HealthCor Management withdrew a net $480M in Q2 2021, closing 42 positions and reducing 20 holdings. Its most notable exit was Incyte, an estimated $95.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 84% a quarter earlier, followed by Consumer Discretionary and Real Estate.

Against the trend, HealthCor Management opened a new position in CVS Health worth $106M.

  • HealthCor Management's largest Q2 2021 buy was CVS Health: 1,267,330 shares worth $106M.
  • HealthCor Management added most to Biogen in Q2 2021, an estimated $78.4M increase.
  • HealthCor Management's biggest Q2 2021 reduction was Vertex Pharmaceuticals, cutting an estimated $115M.
  • HealthCor Management fully exited Incyte in Q2 2021, selling an estimated $95.4M.
  • HealthCor Management's ten largest holdings make up 43% of its $2.5B portfolio in Q2 2021.
  • HealthCor Management opened 31 new positions and closed 42 in Q2 2021.
  • HealthCor Management's portfolio value fell 11% quarter-over-quarter to $2.5B.

Based on HealthCor Management's 13F filing for Q2 2021, filed 16 Aug 2021.